Product Code: GVR-2-68038-053-8
Animal Vaccines Market Growth & Trends:
The global animal vaccines market size is expected to reach USD 25.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.4% from 2024 to 2030. The growing incidence of food-borne zoonotic diseases and increasing animal husbandry are boosting the demand for vaccines. Certain transmissible diseases such as bird flu and tuberculosis in invertebrate animals can be transferred directly or indirectly to humans. If consumers eat worms via undercooked fish, they can get contaminated with anisakiasis, a human zoonotic infection caused by some species of nematodes.
The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are propelling the market growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key growth factors. Competition in the market is expected to be high during the forecast period. The market is highly fragmented owing to the presence of several small and large players. This results in high competition among small players to sustain their position in the market.
Moreover, companies are increasingly adopting strategies, such as mergers & acquisitions, geographic expansion, and the launch of new products, to grow in the market. For instance, in December 2020, Elanco acquired exclusive global rights from Kindred Biosciences to its monoclonal antibody for Canine Parvovirus (CPV) called KIND-030. This strengthened the company's overall vaccine and therapeutics portfolios. Moreover, in September 2020, Ceva enhanced its production capacity at its French facility for bacterial autogenous vaccines. This is expected to support its growth strategy.
Animal Vaccines Market Report Highlights:
- The attenuated live vaccines segment led the market with the largest revenue share of 37.64% in 2023.
- Based on animal type, the livestock segment led the market with the largest revenue share of 71.85% in 2023. This can be attributed to the factors such as the rising livestock population, supportive government initiatives, and the outbreak of diseases among cattle and sheep.
- Based on route of administration, the subcutaneous segment led the market with the largest revenue share of 41.18% in 2023. In most animals, the subcutaneous injection sites are located behind the shoulder blades and neck.
- Based on distribution channel, the hospital/clinic pharmacy segment led the market with the largest revenue share of 19.91% in 2023. Hospital/clinic pharmacies are often at the forefront of adopting new technologies.
- North America dominated the animal vaccines market with the largest revenue share of 29.24% in 2023.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Animal Vaccines Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising livestock population
- 3.2.1.2. Increasing disease outbreak
- 3.2.1.3. Rising R&D and manufacturing advancements
- 3.2.1.4. Growing demand for animal derived food products
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack of awareness
- 3.2.2.2. High cost of care
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Animal Vaccines Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Animal Population by key countries, key species, 2023
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Animal Vaccines Market: Animal Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Animal Vaccines Market: Animal type Movement Analysis
- 4.3. Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
- 4.4. Livestock
- 4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Poultry
- 4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Aqua
- 4.4.3.1. Aqua Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Ruminant
- 4.4.4.1. Ruminant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Swine
- 4.4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Companion
- 4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Canine
- 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Feline
- 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Others
- 4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Animal Vaccines Market: By Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Animal Vaccines Market: By Product Movement Analysis
- 5.3. Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
- 5.3.1. Attenuated Live Vaccines
- 5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Inactivated Vaccines
- 5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Subunit Vaccines
- 5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.4. DNA Vaccines
- 5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.5. Recombinant Vaccines
- 5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Animal Vaccines Market: By Route of Administration Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Animal Vaccines Market: By Route of Administration Movement Analysis
- 6.3. Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
- 6.3.1. Subcutaneous
- 6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Intramuscular
- 6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Intranasal
- 6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Animal Vaccines Market: By Distribution Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Animal Vaccines Market: By Distribution Channel Movement Analysis
- 7.3. Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
- 7.3.1. Retail
- 7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. E-Commerce
- 7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Hospital/Clinic Pharmacy
- 7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Animal Vaccines Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Animal Vaccines Market Share, By Region, 2023 & 2030 (USD Million)
- 8.3. Regional Outlook
- 8.4. North America
- 8.4.1. North America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. U.S. Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Canada Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Mexico Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5. Europe
- 8.5.1. Europe Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. UK
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. UK Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Germany Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. France Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Italy Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Spain Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Denmark
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Denmark Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Sweden
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Sweden Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Norway
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Norway Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Japan Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. China Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. India Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Australia
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Australia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. South Korea
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. South Korea Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Thailand Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Latin America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Brazil Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Argentina Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8. Middle East & Africa
- 8.8.1. Middle East & Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. South Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Saudi Arabia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. UAE Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Kuwait Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Company Market Position Analysis/ Heap Map Analysis
- 9.3. Company Profiles
- 9.3.1. Merck & Co., Inc.
- 9.3.1.1. Participant's Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Zoetis
- 9.3.2.1. Participant's Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Virbac
- 9.3.3.1. Participant's Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Elanco
- 9.3.4.1. Participant's Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Boehringer Ingelheim Animal Health
- 9.3.5.1. Participant's Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Phibro Animal Health Corporation
- 9.3.6.1. Participant's Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Calier
- 9.3.7.1. Participant's Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Ceva
- 9.3.8.1. Participant's Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Product Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Bimeda Biologicals
- 9.3.9.1. Participant's Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Product Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Neogen Corporation
- 9.3.10.1. Participant's Overview
- 9.3.10.2. Financial Performance
- 9.3.10.3. Product Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.4. Strategy Mapping
- 9.4.1. Mergers & Acquisitions
- 9.4.2. Partnerships & Collaborations
- 9.4.3. Expansion
- 9.4.4. Product launch
- 9.4.5. Product Approval
- 9.4.6. Others
- 9.5. List of other key players